Pooled analysis of patient (pt)-reported outcomes (PROs) in the MONALEESA (ML)-2,-3, and-7 trials: Additional results and key subgroup findings

Simple item page
dc.conference.dateMAY 05-08, 2021
dc.conference.titleESMO Breast Cancer Virtual Congress
dc.contributor.authorFasching, P. A.
dc.contributor.authorBardia, A.
dc.contributor.authorNusch, A.
dc.contributor.authorJerusalem, G.
dc.contributor.authorChan, A.
dc.contributor.authorEl Saghir, N. S.
dc.contributor.authorConejo, E. Alba
dc.contributor.authorIm, S-A.
dc.contributor.authorJanni, W.
dc.contributor.authorChandiwana, D.
dc.contributor.authorLanoue, B. R.
dc.contributor.authorThuerigen, A.
dc.contributor.authorGu, E.
dc.contributor.authorHarbeck, N.
dc.contributor.authoraffiliation[Fasching, P. A.] Univ Klinikum Erlangen, Dept Gynecol & Obstet, Erlangen, Germany
dc.contributor.authoraffiliation[Bardia, A.] Massachusetts Gen Hosp, Ctr Canc, Med Oncol, Boston, MA USA
dc.contributor.authoraffiliation[Jerusalem, G.] CHU Liege, Med Oncol, Liege, Belgium
dc.contributor.authoraffiliation[Jerusalem, G.] Univ Liege, Liege, Belgium
dc.contributor.authoraffiliation[Chan, A.] Breast Canc Res Ctr BCRC WA, Med Oncol, Nedlands, WA, Australia
dc.contributor.authoraffiliation[El Saghir, N. S.] AUBMC Amer Univ Beirut Med Ctr, Dept Internal Med, Beirut, Lebanon
dc.contributor.authoraffiliation[Conejo, E. Alba] Hosp Univ Virgen de la Victoria, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Im, S-A.] SNUH Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
dc.contributor.authoraffiliation[Janni, W.] Ulm Med Univ, Frauenklin, Ulm, Germany
dc.contributor.authoraffiliation[Chandiwana, D.] Novartis, Med Oncol, E Hanover, NJ USA
dc.contributor.authoraffiliation[Lanoue, B. R.] Novartis Pharmaceut, Global Value & Access, E Hanover, NJ USA
dc.contributor.authoraffiliation[Thuerigen, A.] Novartis Pharma AG, Oncol Med Affairs, Basel, Switzerland
dc.contributor.authoraffiliation[Gu, E.] Novartis Pharmaceut, Breast Oncol, E Hanover, NJ USA
dc.contributor.authoraffiliation[Harbeck, N.] Ludwig Maximilians Univ Grosshadern, Breast Ctr, Munich, Germany
dc.contributor.funderNovartis Pharmaceuticals Corporation
dc.date.accessioned2025-01-07T15:20:56Z
dc.date.available2025-01-07T15:20:56Z
dc.date.issued2021-05-08
dc.identifier.doi10.1016/j.annonc.2021.03.105
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753421009832/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27058
dc.identifier.wosID648924400095
dc.issue.number2
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.page.numberS60-S61
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePooled analysis of patient (pt)-reported outcomes (PROs) in the MONALEESA (ML)-2,-3, and-7 trials: Additional results and key subgroup findings
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía